AKESO

09926

----

Current ValuationThe current P/E ratio is -73.19, within the reasonable range, cheaper than 67.1% of the time in the past 5 years, and the industry ranks 73/78, the industry Median -5.05.

-73.19xP/E

Stock priceHK$86.60Earnings per shareHK$-1.18

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0159318477636

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
09926HKAKESO	-73.19x	75.71%	HK$81.50B
09688HKZAI LAB	-13.71x	378.87%	HK$20.23B
01877HKJUNSHI BIO	-37.09x	85.34%	HK$17.17B
09606HKDUALITYBIO-B	-8.26x	85.62%	HK$13.68B
07666HKMETIS TECHBIO-P	-30.74x	96.71%	HK$12.51B
02627HKAB&B BIO-TECH-B	-46.87x	--	HK$11.54B
02595HKGENFLEET-B	-7.57x	66.07%	HK$11.48B
06855HKASCENTAGE	-6.73x	18.76%	HK$11.38B
01952HKEVEREST MED	-174.95x	324.72%	HK$10.86B
02493HKMABWELL-B	-7.93x	--	HK$8.58B
06938HKRIBOLIFE-B	-41.66x	29.56%	HK$8.14B
02616HKCSTONE PHARMA-B	-16.11x	1.77%	HK$7.77B
09887HKLEADS BIOLABS-B	-23.17x	3.57%	HK$7.12B
02171HKCARSGEN-B	-64.88x	51.05%	HK$6.66B
09966HKALPHAMAB-B	-31.62x	--	HK$6.41B
01672HKASCLETIS-B	-8.70x	78.53%	HK$5.93B
06872HKTENNOR THERAP-B	-31.24x	--	HK$5.01B
02256HKABBISKO-B	-9.22x	800.99%	HK$4.95B
02335HKMICOT PHARMA-B	-11.40x	37.52%	HK$4.78B
00775HKCKLIFE SCIENCES	-72.79x	--	HK$4.71B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.